Morning Seminar June 10, 2008
Pediatr Blood Cancer. 2008 Jul;51(1):23-8.
Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
Spreafico F, Bisogno G, Collini P, Jenkner A, Gandola L, D'Angelo P, Casazza G, Piva L, Luksch R, Perotti D, Pession A, Fagioli F, Dallorso S.
Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: experience by the Italian Association of Pediatric Hematology and Oncology.
Spreafico F, Bisogno G, Collini P, Jenkner A, Gandola L, D'Angelo P, Casazza G, Piva L, Luksch R, Perotti D, Pession A, Fagioli F, Dallorso S.
posted by hohtaped @ 8:23 AM
<< Home